![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Morphea - 14 Studies Found
Withdrawn |
: Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study : Morphea : 2005-09-28 : Drug: imiquimod 5% cream (Aldara) |
Completed |
: Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea. : Symmetric Limited Morphea. : 2008-12-18 :
|
Terminated |
: Molecular Effects of Topical Calcipotriene on Morphea :
: 2015-03-03 : Drug: topical calcipotriene 0.005% ointment Affected area will be treated twice daily for 3 months |
Recruiting |
: Genetic Variants in Linear Localized Scleroderma : Morphea : 2014-07-21 : Other: skin biopsy |
Recruiting |
: Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma : Localized Scleroderma : 2013-09-05 :
|
Recruiting |
: Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea :
|
Recruiting |
: Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository :
|
Completed |
: Imiquimod in Children With Plaque Morphea : Scleroderma, Localized : 2005-09-02 : Drug: Imiquimod 5% cream Treatment will last for 36 weeks. Patients will be instructed to apply Imiquimo |
Withdrawn |
: Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea : Scleroderma : 2016-02-09 :
|
Withdrawn |
: A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy : Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis) : 2009-07-09 : Drug: Rituximab Mabthera, Rituximab 1000 mg I.V. |